Adaptive Biotechnologies Corp.

AT CELLCARTA WE ARE DEDICATED TO WORKING WITH OUR PARTNERS TO FURTHER THE LIMITLESS POTENTIAL OF PRECISION MEDICINE

As a global contract research organization (CRO) laboratory, we partner with our clients to address the most complex biomarker and bioanalytical challenges and deliver highly customized testing solutions. With facilities located in Canada, United States, Belgium, Australia and China, CellCarta provides the expertise needed locally to support global clinical trials.

CellCarta offers access to integrated analytical platforms in immunology (immune monitoring), histopathology, proteomics and genomics, as well as sample logistics services.

At CellCarta we are experts at assessing the immune system, whether in the context of oncology, infectious diseases, or autoimmune diseases. With a proven track record in other therapeutic areas as, such as neurological and metabolic disorders, we handle all human biological specimens and deploy relevant technologies to extract valuable information for research and diagnostic applications. We provide assay development and testing services to support a wide variety of translational research, clinical trials, and diagnostic applications.

Committed to delivering the highest quality science and innovation, CellCarta recently acquired Clinical Logistics to expand its specialty specimen logistics and kitting services and Mosaic Laboratories for multiplex immunohistochemistry assays development and deployment.

Reflecting our commitment to quality, our sites hold the appropriate accreditations to support your regulatory requirements, inNeo-Epitope Discoverycluding CAP, CLIA, ISO15189 and ISO13485.

CellCarta is privately held and majority-owned by Arsenal Capital Partners.

Quidel Corporation is a leading manufacturer of diagnostic solutions at the point of care delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the medical device industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted brand names Sofia®, Solana®, Lyra®, Triage® and QuickVue®, Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world.

To avoid fraudulent job listings, search and apply for Quidel career opportunities at https://quidel.link/JobOpportunities.

ImmunoVision is proud to be a member of the Erba Diagnostics family, a part of the global ERBA Mannheim Group. Earlier known by the name of IVAX Diagnostics, the company specializes in the manufacture and marketing of proprietary diagnostic reagents, test kits, and instrumentation in the areas of autoimmune, chemistry, hematology, diabetes, and infectious diseases.

ImmunoVision has been supplying reagents to the autoimmune field since 1985 and is the leader in the autoimmune market. We will continue to broaden our search to help meet the needs of the autoimmune researcher. These endeavors can be seen in every aspect of our company. Our suppliers must meet rigid requirements in order to belong to the ImmunoVision family. Our staff is formed of highly qualified and experienced immunochemists.

ImmunoVision has carefully selected distributors from throughout the world to ensure that each researcher will receive prompt service from a local distributor. The final step in ImmunoVision’s association is about: YOU! And we hope that the new products, as well as the old, will meet your needs. If not, please give us a call at 479-751-7005, and let us help you find what you need.

We look for ways to provide more reliable diagnostics
We develop, produce and distribute diagnostic products

30 years of fascinating discoveries
Desire and enthusiasm for innovation has defined our group since its establishment.

The BioVendor Group in numbers:

6 brands of the BioVendor Group
500+ employees of the BioVendor Group
70+ states with direct representation
5,500+ references of our products
120+ scientists in research

Bridging Science and Diagnostics
Every successful treatment begins with a reliable diagnosis.
At BioVendor Group, we look for ways to provide reliable and affordable laboratory results to physicians and patients around the world.

Our corporate DNA
Diversity is the foundation of our success. Geographically and culturally distant brands are united by a common motivation: to facilitate more reliable and faster diagnostics of patients. The synergy of our companies is the basis of the unique know-how and portfolio of the BioVendor Group.

BioVendor LM
A Czech distributor of IVD products for immunology, clinical biochemistry, haematology, microbiology, molecular biology.
Discover more: www.biovendor.cz

BioVendor R&D
The research center for innovative biomarkers and technologies – miRNA, NGS, liquid biopsies and immunodiagnostic automation.
Discover more: www.biovendor.com

TestLine
A traditional Czech manufacturer and distributor of IVD products focusing on infectious diseases and immunology.
Discover more: www.testlinecd.com

Oxford BioSystems
A distributor of top IVD products in the United Kingdom and Ireland.
Discover more: www.oxfordbiosystems.com

ViennaLab
The development and distribution of user-friendly IVD assays for genetic testing.
Discover more: www.viennalab.com

DiaSource
A manufacturer of products for clinical diagnostics focused on endocrinology, autoimmune and infectious diseases.
Discover more: www.diasource-diagnostics.com

ProteoGenex is an established, innovative provider of biological specimens and clinical information of the highest quality standards.

We are a privately held US company founded in Los Angeles, CA in 2003. With headquarters in Culver City, CA, we also have a large, state-of-the-art research laboratory in Moscow, Russia.

The ProteoGenex team consists of 35 employees, including 30 Molecular Biologists, Cell Biologists, Biochemists, and Pathologists (15 PhDs, 5 MDs, 15 MSs).

Our biorepository offers an extensive inventory of biospecimens as well as an exclusive, custom-design human tissue-based research service, which is the company’s largest and fastest growing business segment.
Our unique and comprehensive biobank is composed of well-defined and categorized clinical samples, including frozen and FFPE tissues, blood, serum, plasma, bone marrow, tissue microarrays, etc. All ProteoGenex specimens are collected from a vast network of academic and professional clinical institutions under strict regulatory and ethical standards.

We have over 200,000 individual biomaterials covering disease targets in the fields of Oncology, Dermatology, Neurology, Immunology, Infectious Diseases, Autoimmune and Metabolic Disorders, and many more. Our products are derived from a variety of diseased human sources as well as from normal tissues. All specimens are supported by extensive pathology information and patient’s’ clinical history documentation.